Chiron Capital Management’s Abbott ABT Stock Holding History

Chiron Capital Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-56	Closed	-$6K	–	85
2020 Q3	$6K	Buy	+56	New	+$5.68K	﹤0.01%	339

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Chiron Capital Management's ABT Position: Q4 2020 in Review

Chiron Capital Management sold out of Abbott (ABT) in Q4 2020, closing a stake of 56 shares — an estimated $6K sold.

Chiron Capital Management first reported a position in ABT in Q3 2020 and held it in 1 quarter. The position peaked at $6K in Q3 2020. 2,488 funds tracked by Wall St. Rank hold ABT as of Q4 2020.

Chiron Capital Management reported no remaining Abbott position as of Q4 2020 after selling out during the quarter.
Chiron Capital Management sold 56 Abbott shares in Q4 2020, an estimated $6K.
Chiron Capital Management first reported a position in Abbott in Q3 2020 and held it in 1 quarter.
Chiron Capital Management's Abbott position peaked at $6K in Q3 2020.
2,488 funds tracked by Wall St. Rank held Abbott as of Q4 2020.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.